When adjusted for HDL cholesterol and apolipoprotein A-I, there was robust evidence for a potential causal role of apolipoprotein B in the development of CHD (adjusted OR 1.68; 95% CI: 1.54–1.84; P < 0.001). Here, APOA1 is linked to coronary artery disorder.